Literature DB >> 14709293

Stability of refraction, accommodation, and lens position after implantation of the 1CU accommodating posterior chamber intraocular lens.

Michael Küchle1, Berthold Seitz, Achim Langenbucher, Peter Martus, Nhung X Nguyen.   

Abstract

PURPOSE: To investigate stability of refraction, anterior chamber depth (ACD), and accommodation up to 12 months after implantation of the 1CU accommodating posterior chamber intraocular lens (PC IOL).
SETTING: Department of Ophthalmology, University Erlangen-Nürnberg, Erlangen, Germany.
METHODS: In a prospective study, 15 eyes of 15 patients (mean age 62.2 years +/- 13.4 [SD] [range 44 to 86 years]) had phacoemulsification and PC IOL implantation. Distance refraction, accommodative range measured by the near point with an accommodometer, ACD measured with the IOLMaster (Carl Zeiss Meditec), and near visual acuity with best distance correction (Birkhäuser charts at 35 cm) were determined after 3, 6, and 12 months and analyzed for signs of systematic changes.
RESULTS: After 3, 6, and 12 months, the mean distance refraction was -0.28 +/- 0.54 diopters (D), -0.29 +/- 0.52 D, and -0.21 +/- 0.54 D, respectively; the mean accommodative range, 1.93 +/- 0.47 D, 1.85 +/- 0.62 D, and 2.02 +/- 0.38 D, respectively; the mean ACD without pharmacological induction of ciliary muscle contraction, 4.40 +/- 0.44 mm, 4.35 +/- 0.50 mm, 4.25 +/- 0.53 mm, respectively; and the mean near visual acuity with best distance correction, 0.41 +/- 0.15, 0.37 +/- 0.12, and 0.39 +/- 0.11, respectively. There were no statistically significant changes in any measurement during the follow-up (P>.1).
CONCLUSIONS: Refraction, ACD, and accommodative range remained stable without indication of a systemic trend toward myopia, hyperopia, PC IOL dislocation, or regression of accommodative properties. The 1CU accommodating PC IOL provided stable refraction, accommodation, and PC IOL position for up to 1 year.

Entities:  

Mesh:

Year:  2003        PMID: 14709293     DOI: 10.1016/s0886-3350(03)00413-9

Source DB:  PubMed          Journal:  J Cataract Refract Surg        ISSN: 0886-3350            Impact factor:   3.351


  8 in total

1.  Paraxial analysis of the depth of field of a pseudophakic eye with accommodating intraocular lens.

Authors:  Jit B Ale; Fabrice Manns; Arthur Ho
Journal:  Optom Vis Sci       Date:  2011-07       Impact factor: 1.973

Review 2.  Accommodating intraocular lenses: a critical review of present and future concepts.

Authors:  R Menapace; O Findl; K Kriechbaum; Ch Leydolt-Koeppl
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2006-08-30       Impact factor: 3.117

3.  Subjective and objective performance of the Lenstec KH-3500 "accommodative" intraocular lens.

Authors:  J S Wolffsohn; S A Naroo; N K Motwani; S Shah; O A Hunt; S Mantry; M Sira; I A Cunliffe; M T Benson
Journal:  Br J Ophthalmol       Date:  2006-03-10       Impact factor: 4.638

4.  Aphakic retropupillary iris-claw intraocular lens (IOL) pseudophakic accommodation.

Authors:  Virgilio Galvis; Alejandro Tello; Néstor I Carreño; Mario L Revelo
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2013-06-04       Impact factor: 3.117

Review 5.  Clinical application of accommodating intraocular lens.

Authors:  You-Ling Liang; Song-Bai Jia
Journal:  Int J Ophthalmol       Date:  2018-06-18       Impact factor: 1.779

6.  Accommodation after Nd: YAG capsulotomy in patients with accommodative posterior chamber lens 1CU.

Authors:  Nhung X Nguyen; B Seitz; S Reese; A Langenbucher; M Küchle
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2004-12-14       Impact factor: 3.117

7.  [Evaluation of the valence objective and subjective methods for measuring pseudophakic accommodation].

Authors:  D Uthoff; W Haigis; D Hepper; M Pölzl; D Holland
Journal:  Ophthalmologe       Date:  2013-05       Impact factor: 1.059

8.  Five Years Follow-Up of Acrysof Cachet® Angle-Supported Phakic Intraocular Lens Implantation for Myopia Correction.

Authors:  Aytan Musayeva; Jana C Riedl; Adrian Gericke; Urs Vossmerbaeumer
Journal:  J Ophthalmol       Date:  2022-03-26       Impact factor: 1.909

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.